文献速递细菌感染、耐药与抗菌药物

VITEK 2与三种梯度条法检测金黄色葡萄球菌达托霉素敏感性的比较评估

Comparative evaluation of VITEK® 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

该研究以肉汤微量稀释法为参考,评估VITEK 2及三种商业梯度条法检测金黄色葡萄球菌达托霉素耐药的能力。结果显示各方法与参考方法的基本一致率为98.1%至100%,分类一致率为98.2%至99.1%,均能检出MRSA和MSSA中的达托霉素非敏感株。结论认为常规实验室按厂商说明使用商业系统时漏检达托霉素耐药的风险有限,但需警惕达托霉素非敏感MSSA增多。

要点

  • VITEK 2与三种梯度条法检测达托霉素敏感性基本一致率98.1%至100%。
  • 各商业系统分类一致率为98.2%至99.1%,均能检出MRSA和MSSA非敏感株。
  • 按厂商说明使用商业系统时,常规实验室漏检达托霉素耐药风险有限。

核心结论

  • 常规实验室按厂商说明使用商业测试系统时,漏检达托霉素耐药发展的风险有限。
  • 实验室需警惕达托霉素非敏感MSSA isolate增多,包括糖肽类MIC升高的菌株。

研究设计与样本

  • 以肉汤微量稀释法为参考,比较VITEK 2和三种商业梯度条法检测代表性金黄色葡萄球菌菌株集合的达托霉素耐药。

主要发现

  • 商业测试系统与参考肉汤微量稀释法的基本一致率为98.1%至100%。
  • 分类一致率为98.2%至99.1%。
  • 所有系统均能检出MRSA和MSSA isolate中的达托霉素非敏感。

关键数值与推荐

  • 基本一致率:98.1%至100%(商业系统 vs 参考肉汤微量稀释法)。
  • 分类一致率:98.2%至99.1%(商业系统 vs 参考肉汤微量稀释法)。

临床怎么用

  • 常规实验室可按厂商说明使用VITEK 2或商业梯度条法检测金黄色葡萄球菌达托霉素敏感性。
  • 应关注达托霉素非敏感MSSA isolate,包括糖肽类MIC升高者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: MRSA remains a major cause of severe nosocomial infections and the increased use of vancomycin and daptomycin for MRSA treatment over the last decade has led to the isolation of MRSA strains with decreased daptomycin susceptibility. In addition, a growing number of MSSA isolates with reduced susceptibility to daptomycin have been described lately. Surveillance of the emergence of such a daptomycin-non-susceptible MSSA population requires prompt and reliable daptomycin susceptibility testing. Therefore, this work aimed to evaluate the ability of commonly used methods to detect daptomycin resistance in clinical microbiological laboratories. METHODS: We used commercially available manual and automated test systems, including VITEK® 2 and three gradient strip assays, in comparison with broth microdilution, to detect daptomycin resistance in a representative Staphylococcus aureus strain collection. RESULTS: We found high inter-assay concordance as well as congruence with the reference method. This is demonstrated by essential agreement between commercial test systems and reference broth microdilution ranging from 98.1% to 100% and by categorical agreement from 98.2% to 99.1%. Thus, all systems used were able to detect daptomycin non-susceptibility in MRSA and MSSA isolates. CONCLUSIONS: Our data indicate that routine laboratories are at limited risk of overlooking further daptomycin resistance development, as long as commercially available test systems are used according to the manufacturer's recommendations. However, laboratories must be aware of an increasing number of daptomycin-non-susceptible MSSA isolates, including those exhibiting elevated MICs of glycopeptides.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Weber RE, Layer F, Klare I, et al. Comparative evaluation of VITEK® 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus. J Antimicrob Chemother. 2017. PMID: 28961857. doi:10.1093/jac/dkx255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。